Company profile
Therabron company profile
Therabron Therapeutics, we are working to change how respiratory diseases are managed. We are aiming to not only provide symptomatic relief, but also to improve long-term health outcomes and reduce healthcare costs. A privately held, clinical-stage, biopharmaceutical corporation, Therabron is developing a new class of drugs from the secretoglobin family of proteins. Our lead product, recombinant human CC10 protein (rhCC10), is a potent anti-inflammatory agent for patients with respiratory diseases.
Business identity
- Website
- http://therabron.com/
- Contact email
- [email protected]
- Phone number
- (240) 205-7271
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $0+
- Founded
- 2007-01-01, Year
Headquarters
- Headquarters
- Barbourmeade, Kentucky, United States
- Postal code
- 20850
- Country code
- US
- Continent
- North America